Compare ETFs: IBB vs. LON:XDWH
IBB
LON:XDWH
Comparison
Average Return
In the past year, IBB returned a total of 52.67%, which is significantly higher than LON:XDWH's 24.22% return. Over the past 10 years, IBB has had annualized average returns of 7.76%, compared to 8.49% for LON:XDWH. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | AMGN | Amgen Inc. | 8.76% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.84% |
| 3 | GILD | Gilead Sciences, Inc. | 7.09% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.01% |
| 5 | ARGX | argenx SE | 3.49% |
| 6 | RVMD | Revolution Medicines, Inc. | 2.91% |
| 7 | NTRA | Natera, Inc. | 2.91% |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.36% |
| 9 | BIIB | Biogen Inc. | 2.34% |
| 10 | ILMN | Illumina, Inc. | 2.34% |
| 11 | ONC | BeOne Medicines AG | 2.02% |
| 12 | INCY | Incyte Corporation | 1.84% |
| 13 | UTHR | United Therapeutics Corporation | 1.65% |
| 14 | INSM | Insmed Incorporated | 1.65% |
| 15 | MRNA | Moderna, Inc. | 1.58% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.38% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.24% |
| 18 | GMAB | Genmab A/S | 1.18% |
| 19 | ASND | Ascendis Pharma A/S | 1.17% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.07% |
| 21 | EXEL | Exelixis, Inc. | 1.07% |
| 22 | MEDP | Medpace Holdings, Inc. | 1.05% |
| 23 | CRL | Charles River Laboratories International, Inc. | 0.96% |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.89% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.88% |
| View IBB holdings | |||
| LON:XDWH - Xtrackers MSCI World Health Care UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | LLY | Eli Lilly and Company | 11.81% |
| 2 | JNJ | Johnson & Johnson | 7.50% |
| 3 | ABBV | AbbVie Inc. | 5.46% |
| 4 | UNH | UnitedHealth Group Incorporated | 4.62% |
| 5 | MRK | Merck & Co., Inc. | 3.89% |
| 6 | SWX: ROP | Roche Holding AG | 3.55% |
| 7 | SWX: NOVN | Novartis AG | 3.52% |
| 8 | LON: AZN | AstraZeneca PLC | 3.47% |
| 9 | AMGN | Amgen Inc. | 2.39% |
| 10 | TMO | Thermo Fisher Scientific Inc. | 2.28% |
| 11 | ABT | Abbott Laboratories | 1.94% |
| 12 | GILD | Gilead Sciences, Inc. | 1.92% |
| 13 | CPH: NOVO.B | Novo Nordisk A/S | 1.90% |
| 14 | ISRG | Intuitive Surgical, Inc. | 1.73% |
| 15 | PFE | Pfizer Inc. | 1.68% |
| 16 | CVS | CVS Health Corporation | 1.61% |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 1.55% |
| 18 | DHR | Danaher Corporation | 1.49% |
| 19 | BMY | Bristol-Myers Squibb Company | 1.44% |
| 20 | SYK | Stryker Corporation | 1.33% |
| 21 | LON: GSK | GSK plc | 1.31% |
| 22 | MDT | Medtronic plc | 1.23% |
| 23 | EPA: SAN | Sanofi | 1.15% |
| 24 | MCK | McKesson Corporation | 1.13% |
| 25 | ELV | Elevance Health, Inc. | 1.04% |
| View LON:XDWH holdings | |||